New Delhi, Jan 23 (PTI) Drug firm Granules India on Tuesday said its consolidated profit after tax rose 1 per cent to Rs 126 crore for the third quarter ended December 2023.

The company had reported a net profit of Rs 124 crore in the October-December period of last fiscal.

Also Read | GUJCET Exam 2024: Registration Date for Gujarat Common Entrance Test Examination Extended Till January 31, Apply Online at gsebeservice.com.

Its revenue from operations increased to Rs 1,156 crore in the period under review from Rs 1,146 crore in the year-ago period, Granules India said in a regulatory filing.

"We had a steady performance this quarter, which is reflected in our improved EBITDA and PAT margins as compared to the previous quarter," Granules India Chairman & Managing Director Krishna Prasad Chigurupati said.

Also Read | Explainer on Union Budget of India: Everything You’ve Ever Wanted To Know About an Interim Budget.

The US formulations business has done well in the third quarter, led by both existing and new products, he added.

Shares of the company ended 1.27 per cent down at Rs 411.45 apiece on the BSE.

(The above story is verified and authored by Press Trust of India (PTI) staff. PTI, India’s premier news agency, employs more than 400 journalists and 500 stringers to cover almost every district and small town in India.. The views appearing in the above post do not reflect the opinions of LatestLY)